| dc.description.abstract |
Background: The increasing prevalence of non-communicable diseases
(NCDs), particularly hypertension, poses a global health challenge.
Hypertension is a significant risk factor for cardiovascular diseases and stroke,
with emerging evidence suggesting its association with liver dysfunction.
Elevated liver enzymes such as ALT, AST, and ALP are potential markers of
non-alcoholic fatty liver disease (NAFLD) and related conditions, which may
contribute to hypertension's pathophysiology. This study aims to estimate serum
liver enzyme levels in hypertensive and normotensive individuals and evaluate
the correlation between serum liver enzymes and hypertension.
Materials and Methods: A hospital-based cross-sectional study was conducted
at B.L.D.E (DU) Shri B.M. Patil Medical College with 140 participants, divided
into hypertensive and normotensive groups. Liver enzyme levels were measured
alongside other clinical parameters. Inclusion criteria included individuals aged
≥18 years with no history of hepatotoxic drug use or severe liver disease. Data
were analyzed using SPSS v20, employing t-tests, Mann-Whitney U tests, and
Chi-square tests to compare groups. A p-value <0.05 was considered
statistically significant.
Results: The mean age of participants was 55.66±11.1 years, with a majority
being male. Routine blood parameters did not differ significantly between
groups. However, hypertensive individuals exhibited significantly higher mean
levels of ALT, AST, and ALP (p<0.05) compared to normotensive participants.
Conclusion: The study highlights a significant association between elevated
liver enzymes and hypertension, suggesting liver dysfunction's potential role in
hypertension's pathophysiology. Integrating liver enzyme assessments in
hypertension management may provide insights into underlying mechanisms
and identify individuals at risk for liver-related complications. Further studies
are warranted to validate these findings and their clinical implications. |
en_US |